Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000197444 | SCV000249859 | uncertain significance | not provided | 2024-07-12 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (gnomAD); Not located in the triple helical region, where the majority of pathogenic missense variants occur (PMID: 22696272; HGMD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 22696272) |
Labcorp Genetics |
RCV002229067 | SCV001198123 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345698 | SCV002650543 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-08-29 | criteria provided, single submitter | clinical testing | The p.A1823V variant (also known as c.5468C>T), located in coding exon 66 of the COL5A1 gene, results from a C to T substitution at nucleotide position 5468. The alanine at codon 1823 is replaced by valine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |